文獻精選 - Cusabio 2018年3月 ELISA 文獻引用精選 2018/04/01

Cusabio 成立於2007年,致力於研究開發Antibody、ELISA kit以及 Recombinant Protein,擁有最多樣化的品項,不管是冷門物種抗體、活性重組蛋白,提供給全球學校、政府研究機構、診斷試劑藥廠以及生物製藥公司高品質的產品。

目前Cusabio所開發出的ELISA試劑盒,已經在全世界廣泛被使用。引用文獻多達3900多篇。統計今年2018年3月份,Impact Factor >5 已累計有11篇

 

Title Cata# Journal IF Year
Visceral adipose tissue immune homeostasis is regulated by the crosstalk between adipocytes and dendritic cell subsets CSB-EL026130MO Cell Metab 17.303 2018
Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast CSB-E13445h
 
Circ Res 11.551 2018
Chemotherapy induces breast cancer stemness in association with dysregulated monocytosis CSB-E07426m Clin Cancer Res 8.738 2018
Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence CSB-PA006710GA01HU PLoS Genet 6.661 2018
A nano silicon adjuvant enhances inactivated transmissible gastroenteritis vaccine through activation the Toll-like receptors and promotes humoral and cellular immune responses CSB-E04578m
CSB-E04741m
CSB-E04639m
Nanomedicine 5.671 2018
Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimers Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway CSB-EL023413RA
CSB-E08385r
Mol Neurobiol 5.397 2018
miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma CSB-EL026138HU
CSB-E04760h
Cell Death Dis 5.378 2018
Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways CSB-E08854r Sci Rep. 5.228 2018
Association of NF-E2 Related Factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus CSB-EL015752HU Sci Rep 5.228 2018
Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway CSB-E04741m Journal of Experimental & Clinical Cancer Research 5.189 2018

 

gotop link
客製化服務 產品 聯絡我們
0